Agilent Technologies Inc (A)
154.23
-0.08
(-0.05%)
USD |
NYSE |
May 17, 16:00
154.32
+0.09
(+0.06%)
Pre-Market: 20:00
Agilent Technologies Revenue (Annual): 6.833B for Oct. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| October 31, 2023 | 6.833B |
| October 31, 2022 | 6.848B |
| October 31, 2021 | 6.319B |
| October 31, 2020 | 5.339B |
| October 31, 2019 | 5.163B |
| October 31, 2018 | 4.914B |
| October 31, 2017 | 4.472B |
| October 31, 2016 | 4.202B |
| October 31, 2015 | 4.038B |
| October 31, 2014 | 4.048B |
| October 31, 2013 | 3.894B |
| October 31, 2012 | 6.858B |
| October 31, 2011 | 6.615B |
| Date | Value |
|---|---|
| October 31, 2010 | 5.444B |
| October 31, 2009 | 4.481B |
| October 31, 2008 | 5.774B |
| October 31, 2007 | 5.42B |
| October 31, 2006 | 4.973B |
| October 31, 2005 | 4.685B |
| October 31, 2004 | 4.556B |
| October 31, 2003 | 4.468B |
| October 31, 2002 | 6.01B |
| October 31, 2001 | 8.396B |
| October 31, 2000 | 9.361B |
| October 31, 1999 | 6.83B |
| October 31, 1998 | 7.952B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
5.163B
Minimum
2019
6.848B
Maximum
2022
6.100B
Average
6.319B
Median
2021
Revenue (Annual) Benchmarks
| Bio-Rad Laboratories Inc | 2.671B |
| Revvity Inc | 2.751B |
| Azenta Inc | 665.07M |
| Harvard Bioscience Inc | 112.25M |
| Bionano Genomics Inc | 36.12M |